用于研究蛋白质磷酸化的磷酸化特异性抗体的开发与应用。 - Suppr | 超能文献

The development and use of phospho-specific antibodies to study protein phosphorylation.

作者信息

Blaydes J P, Vojtesek B, Bloomberg G B, Hupp T R

机构信息

Department of Molecular and Cellular Pathology, Ninewells Hospital and Medical School, University of Dundee, UK.

出版信息

Methods Mol Biol. 2000;99:177-89. doi: 10.1385/1-59259-054-3:177.

DOI:10.1385/1-59259-054-3:177

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The development and use of phospho-specific antibodies to study protein phosphorylation.用于研究蛋白质磷酸化的磷酸化特异性抗体的开发与应用。

Methods Mol Biol. 2000;99:177-89. doi: 10.1385/1-59259-054-3:177.

2

Synthesis of complex phosphopeptides as mimics of p53 functional domains.合成复杂磷酸肽作为p53功能域的模拟物。

J Pept Sci. 2002 Nov;8(11):621-33. doi: 10.1002/psc.422.

3

New monoclonal antibodies recognizing p53 protein phosphorylated by casein kinase II at serine 392.识别酪蛋白激酶II在丝氨酸392位点磷酸化的p53蛋白的新型单克隆抗体。

Folia Biol (Praha). 2001;47(4):148-51.

4

Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: anti-idiotypes to the anti-p53 antibody are anti-DNA.针对p53 DNA结合结构域的单克隆抗体模拟DNA的电荷结构：抗p53抗体的抗独特型抗体为抗DNA抗体。

Eur J Immunol. 2004 Dec;34(12):3623-32. doi: 10.1002/eji.200425371.

5

Generation and application of phospho-specific antibodies for p53 and pRB.针对p53和pRB的磷酸化特异性抗体的产生与应用。

Methods Mol Biol. 2003;223:17-26. doi: 10.1385/1-59259-329-1:17.

6

In situ dephosphorylation of p53 protein by calf intestinal alkaline phosphatase treatment.通过小牛肠碱性磷酸酶处理对p53蛋白进行原位去磷酸化。

Oncogene. 1992 Nov;7(11):2351-3.

7

Detection and isolation of recombinant proteins from mammalian cells by immunoaffinity chromatography: p53.

Methods Mol Biol. 1997;63:161-72. doi: 10.1385/0-89603-481-X:161.

8

Comparison of anti-p53 antibodies in immunoblotting.免疫印迹法中抗 p53 抗体的比较。

Biochem Biophys Res Commun. 2002 May 3;293(2):850-6. doi: 10.1016/S0006-291X(02)00298-X.

9

Signaling to p53: the use of phospho-specific antibodies to probe for in vivo kinase activation.

Methods Mol Biol. 2003;234:171-202. doi: 10.1385/1-59259-408-5:171.

10

Preparation and application of antibodies to phosphoamino acid sequences.磷酸化氨基酸序列抗体的制备与应用。

Biopolymers. 2001;60(1):61-75. doi: 10.1002/1097-0282(2001)60:1<61::AID-BIP1004>3.0.CO;2-4.

引用本文的文献

1

Tailor-Made Detection of Individual Phosphorylated and Non-Phosphorylated EPIYA-Motifs of Oncoprotein CagA.定制检测癌蛋白CagA的单个磷酸化和非磷酸化EPIYA基序

Cancers (Basel). 2019 Aug 13;11(8):1163. doi: 10.3390/cancers11081163.

2

Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains.对识别东亚型幽门螺杆菌菌株CagA中单个磷酸化EPIYA基序的磷酸酪氨酸抗体的系统分析。

BMC Microbiol. 2016 Sep 2;16(1):201. doi: 10.1186/s12866-016-0820-6.

3

Role of Protein Tyrosine Phosphatases in Plants.蛋白酪氨酸磷酸酶在植物中的作用。

Curr Genomics. 2015 Aug;16(4):224-36. doi: 10.2174/1389202916666150424234300.

4

Measuring Gli2 Phosphorylation by Selected Reaction Monitoring Mass Spectrometry.通过选择反应监测质谱法测量Gli2磷酸化水平

Methods Mol Biol. 2015;1322:105-23. doi: 10.1007/978-1-4939-2772-2_10.

5

Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.将基于质谱的磷酸化蛋白质组学从发现阶段转化为临床应用所面临的分析挑战。

Electrophoresis. 2014 Dec;35(24):3430-40. doi: 10.1002/elps.201400153. Epub 2014 Jul 10.

6

Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains.系统分析识别西方型幽门螺杆菌菌株 CagA 中单个磷酸化 EPIYA 基序的磷酸酪氨酸抗体。

PLoS One. 2014 May 6;9(5):e96488. doi: 10.1371/journal.pone.0096488. eCollection 2014.

7

Epi-fluorescence microscopy.落射荧光显微镜术

Methods Mol Biol. 2013;931:29-59. doi: 10.1007/978-1-62703-056-4_2.

8

Signal processing by protein tyrosine phosphorylation in plants.植物中蛋白质酪氨酸磷酸化的信号处理。

Plant Signal Behav. 2011 Jul;6(7):942-51. doi: 10.4161/psb.6.7.15261.

9

Strategies for manipulating the p53 pathway in the treatment of human cancer.在人类癌症治疗中操控p53信号通路的策略。

Biochem J. 2000 Nov 15;352 Pt 1(Pt 1):1-17.